Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy

Epilepsy Research

Volumn 108, Issue 3, 2014, Pages 592-596

  Liimatainen, Suvi ^a   Peltola, Jukka ^a   Hietaharju, Aki ^a   Sabater, Lidia ^b   Lang, Bethan ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Autoimmune encephalitis; Neuronal antibody; New onset epilepsy; Polyautoimmunity; Refractory epilepsy; Seizure

Indexed keywords

CARDIOLIPIN ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL;

AUTOIMMUNE ENCEPHALITIS; NEURONAL ANTIBODY; NEW-ONSET EPILEPSY; POLYAUTOIMMUNITY; REFRACTORY EPILEPSY; SEIZURE;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CARDIOLIPINS; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, N-METHYL-D-ASPARTATE; YOUNG ADULT;

EID: 84895443251     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2013.12.015     Document Type: Article

References (29)

1. Bien C.G., Scheffer I.E. Autoantibodies and epilepsy. Epilepsia 2011, 52(Suppl. 3):18-22.
2. Bien C.G., Vincent A., Barnett M.H., Becker A.J., Blümcke I., Graus F., Jellinger K.A., Reuss D.E., Ribalta T., Schlegel J., Sutton I., Lassmann H., Bauer J. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012, 135:1622-1638.
3. Brenner T., Sills G.J., Hart Y., Howell S., Waters P., Brodie M.J., Vincent A., Lang B. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013, 54:1028-1035.
4. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., Dessain S.K., Rosenfeld M.R., Balice-Gordon R., Lynch D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7:1091-1098.
5. Hacohen Y., Absoud M., Woodhall M., Cummins C., De Goede C.G., Hemingway C., Jardine P.E., Kneen R., Pike M.G., Whitehouse W.P., Wassmer E., Waters P., Vincent A., Lim M. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J. Neurol. Neurosurg. Psychiatry 2013, (October). On behalf of UK & Ireland Childhood CNS Inflammatory Demyelination Working Group, (Epub ahead of print).
6. Hansen N., Grünewald B., Weishaupt A., Colaço M.N., Toyka K.V., Sommer C., Geis C. Human stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp. Neurol. 2013, 239:202-209.
7. Honnorat J., Saiz A., Giometto B., Vincent A., Brieva L., de Andres C., Maestre J., Fabien N., Vighetto A., Casamitjana R., Thivolet C., Tavolato B., Antoine J., Trouillas P., Graus F. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch. Neurol. 2001, 58:225-230.
8. Irani S.R., Buckley C., Vincent A., Cockerell O.C., Rudge P., Johnson M.R., Smith S. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008, 71:1647-1648.
9. Kanter I.C., Huttner H.B., Staykov D., Biermann T., Struffertm T., Kerling F., Hilz M.J., Schellinger P.D., Schwab S., Bardutzky J. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 2008, 49:914-920.
10. Kwan P., Arzimanoglou A., Berg A.T., Brodiem M.J., Allen Hauser W., Mathern G., Moshé S.L., Perucca E., Wiebe S., French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 2010, 51:1069-1077.
11. Lehtimäki K.A., Peltola J., Liimatainen S., Haapala A.-M., Arvio M. Cardiolipin and β(2)-glycoprotein I antibodies associate with cognitive impairment and seizure frequency in developmental disorders. Seizure 2011, 20:438-441.
12. Liimatainen S., Peltola M., Fallah M., Kharazmi E., Haapala A.-M., Peltola J. The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur. J. Neurol. 2009, 16:134-141.
13. Liimatainen S., Peltola M., Sabater L., Fallah M., Kharazmi E., Haapala A.-M., Dastidar P., Knip M., Saiz A., Peltola J. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 2010, 51:760-767.
14. Malter M.P., Helmstaedter C., Urbach H., Vincent A., Bien C.G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann. Neurol. 2010, 67:470-478.
15. McKnight K., Jiang Y., Hart Y., Cavey A., Wroe S., Blank M., Shoenfeld Y., Vincent A., Palace J., Lang B. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005, 65:1730-1736.
16. Niehusmann P., Dalmau J., Rudlowski C., Vincent A., Elger C.E., Rossi J.E., Bien C.G. Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy. Arch. Neurol. 2009, 66:458-464.
17. Palace J., Lang B. Epilepsy: an autoimmune disease?. J. Neurol. Neurosurg. Psychiatry 2000, 69:711-714.
18. Peltola J., Kulmala J., Isojärvi J., Saiz A., Latvala K., Palmio J., Savola K., Knip M., Keränen T., Graus F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000, 12:46-50.
19. Peltola J.T., Haapala A.-M., Isojärvi J., Auvinen A., Palmio J., Latvala K., Kulmala P., Laine S., Vaarala O., Keränen T. Antiphosholipid and antinuclear antibodies in epileptic syndromes and newly onset seizure disorders. Am. J. Med. 2000, 109:712-717.
20. Quek A.M., Britton J.W., McKeon A., So E., Lennon V.A., Shin C., Klein C.J., Watson R.E., Kotsenas A.L., Lagerlund T.D., Cascino G.D., Worrell G.A., Wirrell E.C., Nickels K.C., Aksamit A.J., Noe K.H., Pittock S.J. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch. Neurol. 2012, 69:582-593.
21. Ranua J., Luoma K., Peltola J., Haapala A.-M., Raitanen J., Auvinen A., Isojärvi J. Anticardiolipin and antinuclear antibodies in adult patients with epilepsy - a population based cross-sectional study. Epilepsy Res. 2004, 58:13-18.
22. Rosenfeld M.R., Dalmau J.O. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap. Minn.) 2012, 18:366-383.
23. Saiz A., Blanco Y., Sabater L., González F., Bataller L., Casamitjana R., Ramió-Torrentà L., Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
24. Solimena M., Folli F., Aparisi R., Poza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N. Engl. J. Med. 1990, 322:1555-1560.
25. Suleiman J., Brenner T., Gill D., Brilot F., Antony J., Vincent A., Lang B., Dale R.C. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011, 76:1252-1255.
26. Stagg C.J., Lang B., Best J.G., McKnight K., Cavey A., Johansen-Berg H., Vincent A., Palace J. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010, 51:1898-1901.
27. Vincent A., Bien C.G. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol. 2008, 7:1074-1075.
28. Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., Clover L., Parkinson A., Bien C.G., Omer S., Lang B., Rossor M.N., Palace J. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
29. Vincent A., Lily O., Palace J. Pathogenic autoantibodies to neuronal proteins in neurological disorders. J. Neuroimmunol. 1999, 100:169-180.